EUROLAB
ema-guideline-on-stability-testing-for-orally-inhaled-products
Stability Studies (ICH Guidelines) BP Appendix XVI Stability of Finished Products with PreservativesBP Stability Evaluation of Modified Release PreparationsEMA CHMP/QWP/609/2014 Quality Requirements for Stability of BiosimilarsEMA CPMP/QWP/122/02 Stability Testing for Transdermal PatchesEMA Guideline for Stability of Veterinary Medicinal ProductsEMA Guideline on Holding Times for Bulk Products (Stability Implication)EMA Guideline on Stability Testing for Liposomal Drug FormulationsEMA Reflection Paper on Stability for Polymers in Drug DeliveryEMA Reflection Paper on Stability of Advanced Therapies (ATMPs)EMA Stability Testing for Nanoparticle FormulationsEMA Stability Testing in Pediatric FormulationsEMA Stability Testing of Drug-Device Combination ProductsEP 1.2.1 Drug Substance Stability in Multisource SubmissionsEP 2.9.5 Uniformity of Mass Post-Stability TestingEP 3.2.1 Container Closure System Stability EvaluationEP 5.20 Climatic Conditions in Stability Storage ChambersEP 6.0 Stability Testing Requirements for MonographsEP 6.1 Real-Time Stability Testing of Biological ExtractsEP Climatic Zones IVa and IVb for ASEAN and African MarketsFDA 21 CFR 211.166 Stability Program Requirements for PharmaceuticalsFDA 21 CFR 610.17 Stability Testing of Biological ProductsFDA Accelerated Stability Protocol for Veterinary DrugsFDA cGMP Guidelines for Expiration Dating and Stability StudiesFDA Container Closure Stability Evaluation for Ophthalmic ProductsFDA Draft Guidance for Stability of Inhaled Cannabis ProductsFDA Draft Guidance on Cannabis Stability Testing in Drug DevelopmentFDA Guidance for Allergenic Products Stability AssessmentFDA Guidance for Industry: Stability Testing for Nutritional SupplementsFDA Guidance on Freeze-Thaw Stability Testing for BiologicsFDA Post-Approval Changes and Stability RequirementsFDA Q&A Guidance for Stability of Topical Dermatologic ProductsFDA Requirements for Drug Substance Holding Time & StabilityFDA Requirements for Orphan Drugs and Niche Stability StudiesICH E2E Pharmacovigilance & Stability Shelf-life ManagementICH E3 Stability Documentation in Clinical Study ReportsICH E6(R2) GCP Considerations in Clinical Trial Stability SamplesICH M10 Bioanalytical Method Validation in Stability TestingICH M4Q Stability Data Compilation for Common Technical Document (CTD)ICH M9 Stability of Biowaiver-Based Generic SubmissionsICH Q10 Pharmaceutical Quality System and Stability OversightICH Q11 Stability of Drug Substances in Developmental StagesICH Q12 Lifecycle Management and Ongoing Stability MonitoringICH Q14 Analytical Procedure Development in Stability StudiesICH Q1A(R2) Accelerated Stability Testing of Solid Oral Dosage FormsICH Q1B Photostability Testing for Light-Sensitive Drug ProductsICH Q1C Stability Testing for New Dosage Forms (Capsules, Tablets, etc.)ICH Q1D Bracketing and Matrixing Design Stability Protocol DevelopmentICH Q1E Evaluation of Stability Data for Regulatory SubmissionsICH Q1F Stability Data Requirements for Global RegistrationICH Q2(R1) Validation of Analytical Procedures in Stability StudiesICH Q3B(R2) Stability Testing of Impurities in Drug ProductsICH Q3C Residual Solvent Stability in Finished Dosage FormsICH Q4 Guidelines for Pharmacopoeial Stability HarmonizationICH Q4B Annex Stability-Related Harmonization for Global FilingICH Q5C Stability Testing of Biotechnological/Biological ProductsICH Q5D Derivation and Stability of Cell SubstratesICH Q6B Specifications Testing for Biotech Products in Long-Term StudiesICH Q8 Design Space for Stability-Critical ParametersICH Q9 Risk-Based Stability Planning and Protocol DesignICH S3B Photostability of Biologics in Animal StudiesICH S4 Stability of New Veterinary Drug Substances and ProductsICH S6(R1) Preclinical Stability of Biotech ProductsISO 10993-1 Biocompatibility Stability Studies in Medical DevicesISO 11607 Package Integrity Stability for Sterile Medical DevicesISO 13408 Stability Testing of Aseptic Processing SystemsISO 14644 Environmental Monitoring for Stability ChambersISO 14971 Risk Management Related to Stability FailuresISO 15378 GMP for Primary Packaging Stability InteractionsISO 17025 Stability Testing Accreditation RequirementsISO 17034 Reference Material Stability and HomogeneityISO 20387 Stability Assessment in Biobanking Sample StorageISO 21973 Transport Stability of Cell-Based TherapiesISO 9001:2015 Quality System Requirements for Stability ProgramsUSP <1046> Cellular and Gene Therapy Product StabilityUSP <1049> Excipient Stability and Shelf-Life EvaluationUSP <1079> Storage and Stability Testing in Distribution SystemsUSP <1086> Impurities Testing within Stability ProtocolsUSP <1090> Assessment of Drug Product Performance Post StabilityUSP <1118> Monitoring Stability in Storage and Transport ConditionsUSP <1168> Stability Testing for RadiopharmaceuticalsUSP <1191> Stability Considerations in Compounding Pharmacy ProductsUSP <1224> Transfer of Analytical Procedures in Stability StudiesUSP <1225> Validation of Compendial Procedures in Stability ContextUSP <1226> Verification of Compendial Procedures Post-StabilityUSP <671> Stability Testing of Packaging MaterialsUSP <795> Stability Evaluation of Nonsterile PreparationsUSP <797> Stability Testing of Sterile Preparations in CleanroomsWHO Annex 10 Stability Testing of Active Pharmaceutical IngredientsWHO Annex 7 Stability of Reconstituted Lyophilized ProductsWHO Annex 9 Stability for Zoonotic Biological ProductsWHO Good Storage and Distribution Practices for StabilityWHO Guidelines for Stability of DNA and mRNA VaccinesWHO Guidelines on Stability of Combination ARV TherapiesWHO Stability of Monoclonal Antibodies Under Accelerated ConditionsWHO Stability Requirements for Medical Oxygen and InhalersWHO Stability Testing for Pre-Filled Syringes and Auto-InjectorsWHO Temperature Mapping and Qualification of Stability ChambersWHO TRS 1003 Stability Protocols for Combination ProductsWHO TRS 1010 Stability Testing for Vaccines under Cold Chain ConditionsWHO TRS 1019 Stability Testing of Blood and Blood ProductsWHO TRS 953 Climatic Zone-Based Stability Testing for Global MarketsWHO TRS 970 Real-Time Stability Assessment for WHO PrequalificationWHO TRS 992 Long-Term Stability Testing for Herbal Medicinal Products

Comprehensive Guide to EMA Guideline on Stability Testing for Orally Inhaled Products Laboratory Testing Service Provided by Eurolab

The European Medicines Agency (EMA) has established guidelines for stability testing of orally inhaled products, which is a critical aspect of ensuring the quality and safety of these medications. The EMA guideline on stability testing for orally inhaled products outlines the requirements for laboratory testing to assess the physical, chemical, and biological changes that may occur over time.

Relevant Standards

The following international standards are relevant to this testing service:

  • ISO 28592:2015 - Pharmaceuticals -- Stability testing of pharmaceutical products
  • ASTM E1805-08 (2016) - Standard Practice for Stability Testing to Support the Use of Pharmaceutical Water and Water-Related Compounds in the Manufacture of Drug Products
  • EN ISO 14688-1:2009 - Geotechnical investigation and testing Identification and classification of rocks Part 1: Determination of rock strength, density and weathering resistance
  • International and National Standards

    The following national standards are applicable to this testing service:

  • Turkish Standard TSE EN ISO 28592
  • EU Directive 2004/27/EC on the principle of sustainability for environmental protection objectives and waste management
  • Standard Development Organizations

    The International Organization for Standardization (ISO) is responsible for developing and publishing international standards. The American Society for Testing and Materials (ASTM) is a voluntary organization that develops and publishes technical standards.

    Evolution of Standards

    Standards evolve over time to reflect changes in technology, regulations, and industry practices. The EMA guideline on stability testing for orally inhaled products is updated periodically to ensure that it remains relevant and effective.

    Standard Numbers and Scope

    The following standard numbers and scope are relevant to this testing service:

  • ISO 28592:2015 - Stability testing of pharmaceutical products
  • Applies to all pharmaceutical products, including orally inhaled products

    Covers physical, chemical, and biological stability

    Compliance Requirements

    Companies must comply with the EMA guideline on stability testing for orally inhaled products as well as relevant international and national standards. Non-compliance can result in regulatory action, product recalls, or even loss of market authorization.

    Standard-Related Services Provided by Eurolab

    Eurolab provides a comprehensive range of laboratory testing services to ensure compliance with the EMA guideline on stability testing for orally inhaled products. Our experts are experienced in conducting stability tests and ensuring that our clients products meet regulatory requirements.

    ---

    The EMA guideline on stability testing for orally inhaled products is essential for ensuring the quality and safety of these medications. This section explains why this specific test is needed and required, as well as the business and technical reasons for conducting it.

    Why Stability Testing is Needed

    Stability testing is necessary to ensure that pharmaceutical products remain within acceptable limits over time. The EMA guideline on stability testing for orally inhaled products provides a framework for assessing physical, chemical, and biological changes that may occur during storage and transportation.

    Business and Technical Reasons

    The business and technical reasons for conducting stability tests include:

  • Ensuring product quality and safety
  • Preventing regulatory action or product recalls
  • Maintaining market authorization
  • Reducing costs associated with re-testing or re-formulation
  • ---

    This section provides a detailed explanation of how the test is conducted, including testing equipment and instruments used, testing environment requirements, sample preparation procedures, and measurement and analysis methods.

    Testing Equipment and Instruments

    Eurolab uses state-of-the-art equipment and instruments to conduct stability tests, including:

  • Temperature-controlled chambers
  • Humidity control systems
  • Pressure-measuring devices
  • Testing Environment Requirements

    The testing environment must meet specific requirements, including:

  • Temperature: 25C 2C
  • Relative humidity: 60 5
  • Pressure: atmospheric pressure
  • Sample Preparation Procedures

    Samples are prepared according to the EMA guideline on stability testing for orally inhaled products. This includes:

  • Weighting and labeling samples
  • Preparing sample vials or containers
  • Conducting initial analysis of samples
  • ---

    This section explains how test results are documented and reported, including report format and structure, interpretation of test results, certification and accreditation aspects, traceability and documentation requirements, and reporting standards and formats.

    Reporting Test Results

    Eurolab provides detailed reports that include:

  • Summary of testing parameters
  • Results of analysis
  • Conclusion and recommendations
  • Certification and Accreditation Aspects

    Eurolab is accredited by national accreditation bodies to ensure compliance with international standards. Our experts are certified in stability testing and other related areas.

    ---

    This section explains why the EMA guideline on stability testing for orally inhaled products should be performed, including:

  • Ensuring product quality and safety
  • Maintaining regulatory compliance
  • Reducing costs associated with re-testing or re-formulation
  • Enhancing public trust and confidence in pharmaceuticals.
  • ---

    Why Choose Eurolab

    Eurolab is committed to providing high-quality laboratory testing services that meet international standards. Our experts are experienced in conducting stability tests for orally inhaled products, ensuring compliance with the EMA guideline on stability testing for orally inhaled products.

    We provide a comprehensive range of laboratory testing services, including:

  • Stability testing
  • Physical and chemical analysis
  • Microbiological testing
  • Our goal is to ensure that our clients pharmaceutical products meet regulatory requirements, maintain market authorization, and continue to be safe and effective for patients.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers